Shares in Bruker BioSciences briefly climbed to a 52-week high of $5.70 this week, before closing up 11.75 percent to $5.61 on Tuesday. The firm's shares rose this past week after announcing a biodefense contract for the United Arab Emirates. Molecular Devices also hovered near a 52-week high, closing up 8.89 percent for the tracking period ended Tuesday.

Harvard Bioscience led decliners for the week, closing the period down 7.39 percent.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.